Abstract
The intent of treatment in the majority of patients with metastatic colorectal cancer (mCRC) remains palliative, with most unsuitable for potentially radical resection. Approximately 20% of patients with mCRC are potentially suitable for primary resection or metastasis directed therapy including surgical resection, ablation or stereotactic radiotherapy (RT), which may improve their outcomes. We carried out a retrospective analysis of patients with mCRC treated at University College London Hospital (UCLH), evaluating the use of multimodal, potentially curative therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
